81 related articles for article (PubMed ID: 9718864)
1. Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders.
Hjalmar V; Kimby E; Matutes E; Sundström C; Jacobsson B; Arvidsson I; Hast R
Haematologica; 1998 Jul; 83(7):602-9. PubMed ID: 9718864
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
3. Sequential fluorescence in situ hybridization analyses for trisomy 12 in chronic leukemic B-cell disorders.
Hjalmar V; Hast R; Kimby E
Haematologica; 2001 Feb; 86(2):174-80. PubMed ID: 11224487
[TBL] [Abstract][Full Text] [Related]
4. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
[TBL] [Abstract][Full Text] [Related]
5. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
6. Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization.
Tabernero MD; San Miguel JF; Garcia JL; Garcia-Isidoro M; Wiegant J; Ciudad J; Gonzalez M; Rios A; Raap A; Orfao A
Cytometry; 1995 Sep; 22(3):217-22. PubMed ID: 8556953
[TBL] [Abstract][Full Text] [Related]
7. Trisomy 8 in B-cell chronic lymphocytic leukemia.
Pozdnyakova O; Stachurski D; Hutchinson L; Ramakrishnan S; Miron PM
Cancer Genet Cytogenet; 2008 May; 183(1):49-52. PubMed ID: 18474297
[TBL] [Abstract][Full Text] [Related]
8. Atypical lymphocytes in B-cell chronic lymphocytic leukemia and trisomy 12 studied by conventional staining combined with fluorescence in situ hybridization.
Hjalmar V; Kimby E; Matutes E; Sundström C; Wallvik J; Hast R
Leuk Lymphoma; 2000 May; 37(5-6):571-6. PubMed ID: 11042517
[TBL] [Abstract][Full Text] [Related]
9. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
11. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
12. Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.
Porpaczy E; Bilban M; Heinze G; Gruber M; Vanura K; Schwarzinger I; Stilgenbauer S; Streubel B; Fonatsch C; Jaeger U
Eur J Clin Invest; 2009 Jul; 39(7):568-75. PubMed ID: 19453646
[TBL] [Abstract][Full Text] [Related]
13. Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia.
Garcìa-Marco JA; Price CM; Ellis J; Morey M; Matutes E; Lens D; Colman S; Catovsky D
Leukemia; 1996 Nov; 10(11):1705-11. PubMed ID: 8892671
[TBL] [Abstract][Full Text] [Related]
14. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
15. Morphologic identification of atypical chronic lymphocytic leukemia by digital microscopy.
Marionneaux S; Maslak P; Keohane EM
Int J Lab Hematol; 2014 Aug; 36(4):459-64. PubMed ID: 24400650
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
17. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
18. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
19. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
